Cannot stress TEVA+MESOBLAST enough, page-2

It's about timeframes.

You can also say Celgene is more important because it will have more applications than Teva.

CHF is huge no doubt about it because of the savings involved.

I've been saying that

- fast tracking by FDA was inevitable, I said that over a year ago, probably longer if I went back and checked and it was pooh poohed in here. Ridiculed by the likes of madamswer, fruitbat2, and many others who made it their business to talk MSB down. Now that I've been proved right, where are they now?

- as a result of fast tracking that 2017 is the best case scenario for CHF and nobody give it any mind.

It is all coming to pass. But what's the point of saying it.

You want to believe what you want to believe.

So we have anns on the way that the manipulators, shorters and accumulators (and these aren't all separate btw) won't be able to hold the SP down any longer on, whether it's a partnership deal with Celgene or anns about clinical trials. Take your pick.

So that's why most of the downrampers have disappeared. Only a few left now.